新西兰的“医疗安全”是独立测试Estradot的补丁,因为149名妇女报告说粘合性差和救济效率不高。 New Zealand's Medsafe is independently testing Estradot patches after 149 women reported poor adhesion and ineffective relief.

在新西兰妇女提出149项申诉,报告说对雌雄激素的粘合不力和症状缓解不力之后, " MedSafe " 启动了对雌激素补丁的独立测试。 Medsafe has launched independent testing of Estradot oestrogen patches after 149 complaints from New Zealand women reporting poor adhesion and ineffective symptom relief. 制造商Sandoz承认了大约50宗投诉,并测试了美国批量货物,但MedSafe现在正在利用当地实验室评估新西兰特有批货物,原因是担心测试是否充分。 The manufacturer, Sandoz, acknowledged about 50 complaints and tested U.S. batches, but Medsafe is now assessing New Zealand-specific batches using local labs due to concerns over testing adequacy. 该机构正在调查这一问题是新西兰独有的还是更广泛的国际格局的一部分,联合王国也有类似的报告。 The agency is investigating whether the issue is unique to New Zealand or part of a broader international pattern, with similar reports in the UK. Medsafe正与Sandoz和全球监管者合作,强调透明度和定期更新。 Medsafe is working with Sandoz and global regulators, emphasizing transparency and regular updates. 卫生部保持该产品对大多数用户依然有效。 The Ministry of Health maintains the product remains effective for most users.